Decision making in structure-based drug discovery: visual inspection of docking results

A Fischer, M Smiesko, M Sellner… - Journal of Medicinal …, 2021 - ACS Publications
Molecular docking is a computational method widely used in drug discovery. Due to the
inherent inaccuracies of molecular docking, visual inspection of binding modes is a crucial …

Hierarchical virtual screening approaches in small molecule drug discovery

A Kumar, KYJ Zhang - Methods, 2015 - Elsevier
Virtual screening has played a significant role in the discovery of small molecule inhibitors of
therapeutic targets in last two decades. Various ligand and structure-based virtual screening …

Recent advances in dopamine D2 receptor ligands in the treatment of neuropsychiatric disorders

R Juza, K Musilek, E Mezeiova… - Medicinal Research …, 2023 - Wiley Online Library
Dopamine is a biologically active amine synthesized in the central and peripheral nervous
system. This biogenic monoamine acts by activating five types of dopamine receptors (D1 …

Molecular hybridization: a powerful tool for multitarget drug discovery

P de Sena Murteira Pinheiro, LS Franco… - Expert Opinion on …, 2024 - Taylor & Francis
Introduction The current drug discovery paradigm of 'one drug, multiple targets' has gained
attention from both the academic medicinal chemistry community and the pharmaceutical …

Pharmacophore modeling using site-identification by ligand competitive saturation (SILCS) with multiple probe molecules

W Yu, SK Lakkaraju, EP Raman, L Fang… - Journal of chemical …, 2015 - ACS Publications
Receptor-based pharmacophore modeling is an efficient computer-aided drug design
technique that uses the structure of the target protein to identify novel leads. However, most …

The development of pharmacophore modeling: Generation and recent applications in drug discovery

X Lu, H Yang, Y Chen, Q Li, S He… - Current …, 2018 - ingentaconnect.com
Background: The pharmacophore concept in modern drug research is of great importance
and promotes the development of drug industry as indicated by the number of publications …

Revealing vilazodone's binding mechanism underlying its partial agonism to the 5-HT 1A receptor in the treatment of major depressive disorder

G Zheng, W Xue, F Yang, Y Zhang, Y Chen… - Physical Chemistry …, 2017 - pubs.rsc.org
It has been estimated that major depressive disorder (MDD) will become the second largest
global burden among all diseases by 2030. Various types of drugs, including selective …

A novel in silico scaffold-hopping method for drug repositioning in rare and intractable diseases

M Tanabe, R Sakate, J Nakabayashi, K Tsumura… - Scientific Reports, 2023 - nature.com
In the field of rare and intractable diseases, new drug development is difficult and drug
repositioning (DR) is a key method to improve this situation. In this study, we present a new …

Advantages of structure-based drug design approaches in neurological disorders

M Aarthy, U Panwar, C Selvaraj… - Current …, 2017 - ingentaconnect.com
Objective: The purpose of the review is to portray the theoretical concept on neurological
disorders from research data. Background: The freak changes in chemical response of …

Discovery of aryl-piperidine derivatives as potential antipsychotic agents using molecular hybridization strategy

C Zhu, X Li, B Zhao, W Peng, W Li, W Fu - European Journal of Medicinal …, 2020 - Elsevier
Schizophrenia is a chronic, disabling mental disorder that affects about one percent of
world's population. Drugs acting on multiple targets have been demonstrated to provide …